HEAVY-HYDROGEN DRUGS TURN HEADS, AGAIN

RETURN TO ISSUEPREVNewsNEXTHEAVY-HYDROGEN DRUGS TURN HEADS, AGAINFirms seek to improve drug candidates by selective DEUTERIUM SUBSTITUTIONAMANDA YARNELLView Author Information C&EN BOSTONCite this: Chem. Eng. News 2009, 87, 25, 36–39Publication Date (Print):June 22, 2009Publication History Published online14 November 2010Published inissue 22 June 2009https://pubs.acs.org/doi/10.1021/cen-v087n025.p036https://doi.org/10.1021/cen-v087n025.p036newsACS PublicationsCopyright © 2009 AMERICAN CHEMICAL SOCIETYArticle Views124Altmetric-Citations38LEARN ABOUT THESE METRICSArticle Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.Citations are the number of other articles citing this article, calculated by Crossref and updated daily. Find more information about Crossref citation counts.The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on the Altmetric Attention Score and how the score is calculated. Share Add toView InAdd Full Text with ReferenceAdd Description ExportRISCitationCitation and abstractCitation and referencesMore Options Share onFacebookTwitterWechatLinked InRedditEmail Other access options SUBJECTS:Hydrogen,Hydrogen isotopes,Pharmaceuticals Get e-Alerts